Publication:
Magnetic Resonance Hippocampal Subfield Volumetric Analysis for Differentiating among Healthy Older Adults and Older Adults with Mild Cognitive Impairment or Major Depressive Disorder

dc.contributor.authorDoonyaporn Wongsawaengen_US
dc.contributor.authorOrasa Chawalpariten_US
dc.contributor.authorSiriwan Piyapittayananen_US
dc.contributor.authorTanyaluck Thientunyakiten_US
dc.contributor.authorWeerasak Muangpaisanen_US
dc.contributor.authorKitikan Thana-udomen_US
dc.contributor.authorPanida Charnchaowanishen_US
dc.contributor.authorChanon Ngamsombaten_US
dc.contributor.otherSiriraj Hospitalen_US
dc.date.accessioned2022-08-04T11:03:48Z
dc.date.available2022-08-04T11:03:48Z
dc.date.issued2021-01-01en_US
dc.description.abstractObjective: Depression among older adults is frequently an early symptom of cognitive decline, and is believed to be a risk factor for Alzheimer’s disease (AD). Hippocampal subfield volume loss is found in both mild cognitive impairment (MCI) and major depressive disorder (MDD). We aimed to investigate the potential of MR hippocampal subfield volumetry for discriminating among healthy older adults (HOA) and older adults with MCI or MDD. Materials and Methods: Seventy age-matched subjects (29 non-depressed MCI, 12 MDD, and 29 HOA) underwent 3-Tesla MR imaging (MRI) with high-resolution 3D-T1W-TFE whole brain. Hippocampal subfield volumetric measurements were performed using FreeSurfer software to distinguish among MCI, MDD, and HOA. Subgroup analysis with amyloid PET result was also performed. Results: Significantly smaller bilateral hippocampal tail volume was observed in MCI compared to HOA (p=0.004 and p=0.04 on the left and right side, respectively). The same comparative finding was observed at left HATA (hippocampus-amygdala-transition-area) of MCI (p=0.046). Other regions showed non-significantly smaller size in MCI than in HOA [left molecular layer HP (p=0.06), left whole hippocampus (p=0.06), and left CA1 (p=0.07)]. There was a non-significant trend toward smaller size in almost all 13 subfield hippocampal regions of MCI compared to MDD, even in subgroup analysis with amyloid PET result. Conclusion: MR hippocampal subfield volumetry may have value in routine clinical practice for screening individuals with MCI, and may be a valuable adjunct to amyloid PET study for very early-stage diagnosis of AD.en_US
dc.identifier.citationSiriraj Medical Journal. Vol.73, No.12 (2021), 786-792en_US
dc.identifier.doi10.33192/SMJ.2021.102en_US
dc.identifier.issn22288082en_US
dc.identifier.other2-s2.0-85122234189en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/78535
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85122234189&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleMagnetic Resonance Hippocampal Subfield Volumetric Analysis for Differentiating among Healthy Older Adults and Older Adults with Mild Cognitive Impairment or Major Depressive Disorderen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85122234189&origin=inwarden_US

Files

Collections